| Title | Author(s) | Year | View Count |
 | Genome-wide association study identifies a susceptibility locus for thyrotoxic periodic paralysis at 17q24.3 | Cheung, CL; Lau, KS; Ho, AYY; Lee, KK; Tiu, SC; Lau, EYF; Leung, J; Tsang, MW; Chan, KW; Yeung, CY; Woo, YC; Cheung, EYN; Hung, VHF; Pang, HK; Hung, CS; Sham, PC; Kung, AWC | 2012 | 50 |
| Novel nonsense CDC73 mutations in Chinese patients with parathyroid tumors | Siu, WK; Law, CY; Lam, CW; Mak, CM; Wong, GWK; Ho, AYY; Ho, KY; Loo, KT; Chiu, SC; Chow, LTC; Tong, SF; Chan, AYW | 2011 | 95 |
| Ten-year risk of osteoporotic fractures in postmenopausal Chinese women according to clinical risk factors and BMD T-scores: A prospective study | Kung, AWC; Lee, KK; Ho, AYY; Tang, G; Luk, KDK | 2007 | 54 |
| Genetic and environmental determinants of bone mineral density in Chinese women | Lau, HHL; Ng, MYM; Ho, AYY; Luk, KDK; Kung, AWC | 2005 | 85 |
| Development of a clinical assessment tool in identifying Asian men with low bone mineral density and comparison of its usefulness to quantitative bone ultrasound | Kung, AWC; Ho, AYY; Ross, PD; Reginster, JY | 2005 | 179 |
| Determinants of bone mineral density in Chinese men | Cheung, EYN; Ho, AYY; Lam, KF; Tam, S; Kung, AWC | 2005 | 171 |
| The efficacy and tolerability of risedronate on bone mineral density and bone turnover markers in osteoporotic Chinese women: A randomized placebo-controlled study | Leung, JYY; Ho, AYY; Ip, TP; Lee, G; Kung, AWC | 2005 | 99 |
| Efficacy and tolerability of alendronate once weekly in Asian postmenopausal osteoporotic women | Ho, AYY; Kung, AWC | 2005 | 118 |
| Determinants of peak bone mineral density and bone area in young women | Ho, AYY; Kung, AWC | 2005 | 50 |
 | Efficacy and tolerability of Alendronate once-weekly in postmenopausal osteoportic women | Ho, AYY; Kung, AWC | 2005 | 60 |
| An evaluation of a secondary prevention programme against osteoporosis fractures | Kwok, CF; Chan, SM; Lee, KK; Ho, AYY; Chan, YY; Li, PF; Wong, YW; Leung, F; Luk, KDK; Kung, AWC | 2005 | 63 |
| Determinants of bone mineral density in Asian men | Gu, J; Lee, KK; Cheung, EYN; Lam, KF; Ho, AYY; Tam, S; Kung, AWC | 2005 | 69 |
| Alendronate in primary hyperparathyroidism: A double-blind, randomized, placebo-controlled trial | Khan, AA; Bilezikian, JP; Kung, AWC; Ahmed, MM; Dubois, SJ; Ho, AYY; Schussheim, D; Rubin, MR; Shaikh, AM; Silverberg, SJ; Standish, TI; Syed, Z; Syed, ZA | 2004 | 104 |
| Determinants of peak bone bass in Southern Chinese women | Ho, AYY; Kung, AWC | 2004 | 43 |
| A multi-centered, randomized, double-blind placebo controlled study of risedronate on bone mineral density and bone turnover markers in osteoporotic Chinese women | Kung, AWC; Ip, TP; Leung, J; Lee, G; Ho, AYY | 2004 | 82 |
| Bioavailable testosterone is a risk factor for osteoporotic fracture while bioavailable estradiol is a risk factor for low bone mineral density in men | Cheung, EYN; Ho, AYY; Lam, KF; Tam, SCF; Kung, AWC | 2004 | 133 |
| Association of 12 genetic loci and environmental risk factors with bone mineral density in Chinese | Lau, HL; Ho, AYY; Luk, KDK; Kung, AWC | 2004 | 79 |
| Determinants of bone mineral density in Asian men | Gu, J; Lee, KK; Kwan, EYW; Lam, KF; Ho, AYY; Tam, S; Kung, AWC | 2004 | 100 |
| Lifestyle and hormonal risk factors for bone mineral density in Chinese men | Cheung, EYN; Ho, AYY; Kung, AWC | 2004 | 68 |
| Genetic and environmental determinants of bone mineral density in Chinese women | Lau, HL; Ng, MYM; Ho, AYY; Luk, KDK; Kung, AWC | 2004 | 68 |
|
